Epidiferphane

DRUG2 trials

Sponsors

University of Florida

Conditions

Breast Cancer

Phase 1

Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients

WithdrawnNCT03611985

University of FloridaBreast Cancer

Start: 2020-03-31End: 2023-03-31Updated: 2020-01-13

Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients

RecruitingNCT05074290

University of FloridaBreast Cancer

Start: 2023-03-30End: 2026-12-01Target: 74Updated: 2026-02-17

Related Papers

Abstract P3-12-17: NCT05074290 Phase I/II study of Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients

Clinical Cancer Research2025-06-13